Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 36, 2024 - Issue 5
171
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Economic and clinical burdens and associated health disparities in HIV/AIDS management using big data: potentially inappropriate use and deprescribing of benzodiazepines

, , , &
Pages 604-611 | Received 27 Jul 2020, Accepted 19 Oct 2020, Published online: 19 Nov 2020

References

  • 2019 American Geriatrics Society Beers Criteria Update Expert Panel. (2019). American geriatrics society 2019 updated ags beers criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694. https://doi.org/10.1111/jgs.15767
  • Antiretroviral Therapy Cohort Collaboration. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. The Lancet HIV, 4(8), e349–e356. https://doi.org/10.1016/s2352-3018(17)30066-8
  • Blanco, C., Han, B., Jones, C. M., Johnson, K., & Compton, W. M. (2018). Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the United States. The Journal of Clinical Psychiatry, 79(6). https://doi.org/10.4088/JCP.18m12174
  • Burgess, M. J., Zeuli, J. D., & Kasten, M. J. (2015). Management of HIV/AIDS in older patients-drug/drug interactions and adherence to antiretroviral therapy. HIV AIDS (Auckl), 7, 251–264. https://doi.org/10.2147/hiv.S39655
  • Centers for Disease Control and Prevention. (2019). Estimated HIV incidence and prevalence in the United States, 2010–2016. HIV Surveillance Supplemental Report, 24(1). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
  • Centers for Disease Control and Prevention. (2020a). CDC’s HIV Work Saves Lives and Money. https://www.cdc.gov/nchhstp/budget/infographics/hiv.html
  • Centers for Disease Control and Prevention. (2020b). Estimated HIV incidence and prevalence in the United States, 2014–2018. HIV Surveillance Supplemental Report, 25(1). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
  • Courlet, P., Livio, F., Guidi, M., Cavassini, M., Battegay, M., Stoeckle, M., Buclin, T., Alves Saldanha, S., Csajka, C., Marzolini, C., & Decosterd, L. (2019). Polypharmacy, drug-drug interactions, and inappropriate drugs: New challenges in the aging population with HIV. Open Forum Infectious Diseases, 6(12), ofz531. https://doi.org/10.1093/ofid/ofz531
  • Darke, S., Hall, W., Ross, M., & Wodak, A. (1992). Benzodiazepine use and HIV risk-taking behaviour among injecting drug users. Drug and Alcohol Dependence, 31(1), 31–36. https://doi.org/10.1016/0376-8716(92)90005-w
  • Davies, J., Rae, T. C., & Montagu, L. (2017). Long-term benzodiazepine and Z-drugs use in England: A survey of general practice [corrected]. British Journal of General Practice, 67(662), e609–e613. https://doi.org/10.3399/bjgp17X691865
  • Deka, R., Bryan, C. J., LaFleur, J., Oderda, G., Atherton, A., & Stevens, V. (2018). Benzodiazepines, Health care utilization, and suicidal behavior in veterans with posttraumatic stress disorder. The Journal of Clinical Psychiatry, 79(6). https://doi.org/10.4088/JCP.17m12038
  • Dionne, P. A., Vasiliadis, H. M., Latimer, E., Berbiche, D., & Preville, M. (2013). Economic impact of inappropriate benzodiazepine prescribing and related drug interactions among elderly persons. Psychiatric Services, 64(4), 331–338. https://doi.org/10.1176/appi.ps.201200089
  • Engsig, F. N., Hansen, A. B., Gerstoft, J., Kronborg, G., Larsen, C. S., & Obel, N. (2010). Inpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995–2007. Aids, 24(3), 457–461. https://doi.org/10.1097/QAD.0b013e328332828d
  • Fleishman, J. A., Gebo, K. A., Reilly, E. D., Conviser, R., Christopher Mathews, W., Todd Korthuis, P., Hellinger, J., Rutstein, R., Keiser, P., Rubin, H., & Moore, R. D. (2005). Hospital and outpatient health services utilization among HIV-infected adults in care 2000–2002. Medical Care, 43(9 Suppl), Iii40–Iii52. https://doi.org/10.1097/01.mlr.0000175621.65005.c6
  • Gerlach, L. B., Maust, D. T., Leong, S. H., Mavandadi, S., & Oslin, D. W. (2018). Factors associated with long-term benzodiazepine use among older adults. JAMA Internal Medicine, 178(11), 1560–1562. https://doi.org/10.1001/jamainternmed.2018.2413
  • Greene, M., Steinman, M. A., McNicholl, I. R., & Valcour, V. (2014). Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. Journal of the American Geriatrics Society, 62(3), 447–453. https://doi.org/10.1111/jgs.12695
  • Holbrook, A. M., Crowther, R., Lotter, A., Cheng, C., & King, D. (2000). Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal, 162(2), 225–233.
  • José, R. J., Marshall, N., & Lipman, M. C. (2012). Important antiretroviral drug interactions with benzodiazepines used for sedation during bronchoscopy. Chest, 141(4), 1125. https://doi.org/10.1378/chest.11-2944
  • Kroll, D. S., Nieva, H. R., Barsky, A. J., & Linder, J. A. (2016). Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care. Journal of General Internal Medicine, 31(9), 1027–1034. https://doi.org/10.1007/s11606-016-3740-0
  • López-Centeno, B., Badenes-Olmedo, C., Mataix-Sanjuan, A., Bellón, J. M., Pérez-Latorre, L., López, J. C., Benedí, J., Khoo, S., Marzolini, C., Calvo-Alcántara, M. J., & Berenguer, J. (2020). Potentially inappropriate medications in older adults living with HIV. HIV Medicine, https://doi.org/10.1111/hiv.12883
  • Low, Y., Goforth, H., Preud’homme, X., Edinger, J., & Krystal, A. (2014). Insomnia in HIV-infected patients: Pathophysiologic implications. AIDS Reviews, 16(1), 3–13.
  • Lugoboni, F., Mirijello, A., Faccini, M., Casari, R., Cossari, A., Musi, G., Bissoli, G., Quaglio, G., & Addolorato, G. (2014). Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug and Alcohol Dependence, 142, 105–109. https://doi.org/10.1016/j.drugalcdep.2014.06.020
  • Maust, D. T., Lin, L. A., & Blow, F. C. (2019). Benzodiazepine Use and Misuse Among adults in the United States. Psychiatric Services, 70(2), 97–106. https://doi.org/10.1176/appi.ps.201800321
  • Moore, H. N., Mao, L., & Oramasionwu, C. U. (2015). Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH. AIDS Care, 27(12), 1443–1448. https://doi.org/10.1080/09540121.2015.1109583
  • Moriarty, F., Cahir, C., Bennett, K., & Fahey, T. (2019). Economic impact of potentially inappropriate prescribing and related adverse events in older people: A cost-utility analysis using Markov models. BMJ Open, 9(1), e021832. https://doi.org/10.1136/bmjopen-2018-021832
  • Newville, H., Roley, J., & Sorensen, J. L. (2015). Prescription medication misuse among HIV-infected individuals taking antiretroviral therapy. Journal of Substance Abuse Treatment, 48(1), 56–61. https://doi.org/10.1016/j.jsat.2014.07.013
  • Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72(2), 136–142. https://doi.org/10.1001/jamapsychiatry.2014.1763
  • Pottie, K., Thompson, W., Davies, S., Grenier, J., Sadowski, C. A., Welch, V., Holbrook, A., Boyd, C., Swenson, R., Ma, A., & Farrell, B. (2018). Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Canadian Family Physician Medecin de Famille Canadien, 64(5), 339–351.
  • Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008). Clinical guideline for the evaluation and management of chronic insomnia in adults. Journal of Clinical Sleep Medicine, 04(5), 487–504. https://doi.org/10.5664/jcsm.27286.
  • Vinkers, C. H., & Olivier, B. (2012). Mechanisms underlying tolerance after long-term benzodiazepine use: A future for subtype-selective GABA(A) receptor modulators? Advances in Pharmacological Sciences, 2012, 416864. https://doi.org/10.1155/2012/416864
  • Wandeler, G., Johnson, L. F., & Egger, M. (2016). Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: Comparisons with general population. Current Opinion in HIV and AIDS, 11(5), 492–500. https://doi.org/10.1097/coh.0000000000000298
  • Ware, D., Palella, F. J., Jr., Chew, K. W., Friedman, M. R., D’Souza, G., Ho, K., & Plankey, M. (2018). Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort study from 2004 to 2016. PLoS One, 13(9), e0203890. https://doi.org/10.1371/journal.pone.0203890
  • Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., Gringras, P., Krystal, A., Nutt, D., Selsick, H., & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. Journal of Psychopharmacology, 33(8), 923–947. https://doi.org/10.1177/0269881119855343
  • Yoshimura, K. (2017). Current status of HIV/AIDS in the ART era. Journal of Infection and Chemotherapy, 23(1), 12–16. https://doi.org/10.1016/j.jiac.2016.10.002

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.